Literature DB >> 1996303

Comparison of complications of total hip arthroplasty in rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis.

J Lakatos1, L Csákányi.   

Abstract

Between 1971 and 1985, 3080 arthroplasties were performed. The authors analyze patients reoperated because of primary surgery complications. Of the primary arthroplasties (2889), there were 1788 operations performed for primary osteoarthritis, and 379 hip replacements for rheumatoid arthritis, ankylosing spondylitis, and systemic lupus erythematosus (SLE). Reoperation rates in both groups were the same (3.4%). In the group with rheumatoid arthritis, the rate was 1.45%, much lower than the osteoarthritic group.

Entities:  

Mesh:

Year:  1991        PMID: 1996303     DOI: 10.3928/0147-7447-19910101-10

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  4 in total

1.  How does systemic lupus erythematosus impact the peri-operative complication rates in primary hip arthroplasty? A national inpatient sample-based study.

Authors:  Vibhu Krishnan Viswanathan; Vishaal Sakthivelnathan; Anil Menedal; Prabhudev Prasad Purudappa; Varatharaj Mounasamy; Senthil Sambandam
Journal:  Arch Orthop Trauma Surg       Date:  2022-05-28       Impact factor: 3.067

2.  Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Clin Rheumatol       Date:  2020-03-14       Impact factor: 2.980

3.  Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis.

Authors:  Tim Bongartz; Christine S Halligan; Douglas R Osmon; Megan S Reinalda; William R Bamlet; Cynthia S Crowson; Arlen D Hanssen; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2008-12-15

Review 4.  Incidence and Complication Rates for Total Hip Arthroplasty in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Across Four Decades.

Authors:  Owen Taylor-Williams; Johannes Nossent; Charles A Inderjeeth
Journal:  Rheumatol Ther       Date:  2020-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.